Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease

Human recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease

Introduction: Chronic kidney disease (CKD) can cause anaemia and neurological disorders. Recombinant human erythropoietin (rHuEPO) is used to manage anaemia in CKD. However, there is little evidence on the effects of rHuEPO on behaviour and cognitive function in CKD. This study aimed to evaluate the...

Full description

Bibliographic Details
Main Authors: E.E. Reza-Zaldívar, S. Sandoval-Avila, Y.K. Gutiérrez-Mercado, E. Vázquez-Méndez, A.A. Canales-Aguirre, H. Esquivel-Solís, U. Gómez-Pinedo, A.L. Márquez-Aguirre
Format: Article
Language:English
Published: Elsevier España 2020-04-01
Series:Neurología (English Edition)
Subjects:
Enfermedad renal crónica
Función sensoriomotora
Deterioro cognitivo
Eritropoyetina
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580819300719

Internet

http://www.sciencedirect.com/science/article/pii/S2173580819300719

Similar Items